Michael Birgel practices Internal Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Michael A. Birgel is a published MD as well. He has 7 publications published. The latest was: Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture. Michael Birgel accepts Medicare.
NPI NUMBER | 1619935939 | |
NPPES Provider LastName | BIRGEL | |
NPPES Provider FirstName | MICHAEL | |
NPPES Provider ZIPCode | 85710 | |
NPPES Provider State | AZ | |
Specialty Description | Internal Medicine | |
Total Claim Count | 6217.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 210.0 | |
Percent Opioid Claims | 3.38 |
National Provider Identifier [NPI] | 1619935939 |
Last Name Of The Provider | BIRGEL |
First Name Of The Provider | MICHAEL |
View All |
Dr. Michael S. Enslow, MD | |
Dr. Heidi B. Sutanto, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Charles B. Giffin, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Mayra I. Melendez, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Stephen J. Neustat, MD | |
Dr. Gajapathiraju Chamarthi, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Sarah S. Akhunji, MD | |
Dr. Deborah M. Lindsly, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Rodolfo B. Penaflor Jr., MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Manish M. Shah, MD
This Doctor is OpenDoctor Recommended. |